Anna Andrzejczak

Who I am:

I am currently pursuing my PhD at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences in Wrocław at the Laboratory of Genetics and Epigenetics of Human Diseases.

Prior to my doctoral studies, I have been involved in diverse research projects. Firstly, I participated in an OPUS grant at the Department of Plant Developmental Biology, University of Wroclaw. Subsequently, I joined the Department of Biophysics and Neuroscience at the Medical University of Wroclaw, contributing to the MAESTRO grant focusing on the structure-function relationship of GABAA receptors. Additionally, during the first year of my master’s studies, I received a scholarship from the Wroclaw City Hall for outstanding students going abroad, allowing me to study abroad at Northumbria University, UK, under the ERASMUS program.

Currently immersed in my PhD project I am investigating immune checkpoints and their genetic and epigenetic regulation in cancer. My involvement in this project was appreciated and I received the award of the Director of the Institute of Immunology and Experimental Therapy for the best doctoral project. In addition to my PhD project, I am actively involved in other research projects, collaborating with Wroclaw Medical University, Lower Silesian Center for Oncology, Pulmonology and Hematology, and a local biotechnology company. Moreover, since the end of last year, I have been involved in a project financed by the Medical Research Agency related to the development of CAR-T therapy in the treatment of multiple myeloma.

Throughout my scientific journey, I have made successful contributions to various projects from different fields. Therefore, I am confident that I can thrive in any project I undertake.

My BioLAB work in the lab focuses on:

During the BioLAB program, I will be involved in a collaborative project between Kossiakoff Lab and CaringCross, a not-for-profit pharmaceutical company. The project aims to develop novel technologies to improve the potency and availability of Chimeric Antigen Receptor T-Cells (CAR-T) immunotherapy.

I decided to apply for a BioLAB program because:

From my perspective, the BioLAB program represents a substantial opportunity for professional growth. The program’s collaborative nature provides a unique environment where I can interact with experts, exchange ideas, and establish close collaborations. I believe that participating in BioLAB opens doors for life-changing experiences, both in my professional and personal life.

After completing my BioLAB Program I would like to:

After completing my BioLAB Program, my immediate goal is to defend my PhD thesis. Subsequently, I plan to apply for a PostDoc position either in Poland or abroad, as I aim to continue advancing my scientific career.

  • University of Chicago
Skip to content